Silicosis amelioration by chaetocin: a novel therapeutic strategy targeting the HIF1α-mediated PI3K/AKT/MMP9 pathway
International Immunopharmacology · 2026-06 · 178 · 116593
DOI: 10.1016/j.intimp.2026.116593 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Yujing Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, School of Medicine, Anhui U…. Hauptthemen laut MEDLINE: Silicosis, Hypoxia-Inducible Factor 1, alpha Subunit, Piperazines, Anti-Inflammatory Agents. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Anhui University of Science and Technology, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Silicosis, a debilitating occupational lung fibrosis caused by chronic silica dust inhalation, currently lacks effective therapeutic interventions, and its underlying molecular pathogenesis remains incompletely understood. To address this critical gap, we employed an integrated strategy combining bioinformatics, network pharmacology, and experimental validation to systematically identify novel therapeutic targets and candidate compounds for silicosis. Through analysis of silicosis-related differentially expressed genes from the GEO database and in silico prediction using the cMap platform, we identified the natural product chaetocin as a promising candidate. In a murine model of silicosis, chaetocin administration significantly improved pulmonary function and alleviated lung inflammation and collagen deposition. Notably, at a dose of 1 mg/kg, chaetocin demonstrated superior efficacy to pirfenidone, a current standard-of-care agent. In vitro studies further confirmed that chaetocin effectively attenuated silica-triggered macrophage inflammatory responses, apoptosis, and reactive oxygen species (ROS) production, while also suppressing fibroblast migration and activation. Mechanistic investigations revealed that chaetocin exerts its anti-inflammatory and anti-fibrotic effects by directly targeting HIF1α, thereby inhibiting the downstream PI3K/AKT/MMP9 signaling axis. Collectively, our findings establish chaetocin as a novel naturally-derived therapeutic candidate with significant potential for the treatment of silicosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, School of Medicine, Anhui University of Science and Technology, Huainan City, China; Anhui Provin…
- Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, School of Medicine, Anhui University of Science and Technology, Huainan City, China; The First Af…
Förderung
- Anhui University of Science and Technology
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Anhui Province
Zitieren
APA
Fang, Y., Xu, N., Liang, C., Hu, X., Cai, X., Jing, Y., Tao, H., Hu, D., & Bai, Y. (2026). Silicosis amelioration by chaetocin: a novel therapeutic strategy targeting the HIF1α-mediated PI3K/AKT/MMP9 pathway. International Immunopharmacology, 178, 116593. https://doi.org/10.1016/j.intimp.2026.116593
Vancouver
Fang Y, Xu N, Liang C, Hu X, Cai X, Jing Y, et al. Silicosis amelioration by chaetocin: a novel therapeutic strategy targeting the HIF1α-mediated PI3K/AKT/MMP9 pathway. International Immunopharmacology. 2026;178:116593. doi:10.1016/j.intimp.2026.116593
BibTeX
@article{Fang2026,
author = {Fang, Yujing and Xu, Na and Liang, Chao and Hu, Xiaofei and Cai, Xiaolong and Jing, Yifan and Tao, Huihui and Hu, Dong and Bai, Ying},
title = {Silicosis amelioration by chaetocin: a novel therapeutic strategy targeting the HIF1α-mediated PI3K/AKT/MMP9 pathway},
journal = {International Immunopharmacology},
year = {2026},
volume = {178},
pages = {116593},
doi = {10.1016/j.intimp.2026.116593}
}
EUVIMED